event,time
38 years old , 0
male , 0
admitted to the hospital , 0
HBV-associated PAN , -6 months
medical history of HBV , -6 months
treatment with prednisolone , -6 months
treatment with cyclophosphamide , -6 months
treatment with Tenofovir , -6 months to -2 months
stopped taking Tenofovir , -2 months
chronic renal failure , 0
diabetes mellitus Type II , 0
acute abdomen , 0
septic shock , 0
standing chest radiograph , 0
free sub diaphragmatic air , 0
peritonitis , 0
three perforations of the small intestine , 0
segmental enterectomy with anastomosis , 0
mechanical ventilation , 0
circulatory support , 0
acute-on-chronic renal failure , 0
weaned off the ventilator , 72
haemodynamically stable , 72
treatment with tenofovir , 72
treatment with IV methylprednisolone , 72
abdominal drain catheter presented enteric content , 168
second explorative laparotomy , 168
two new perforations , 168
multiple areas of patchy necrosis , 168
suture repaired , 168
open abdomen , 168
plasma exchanges , 168
IV cyclophosphamide , 168
IV methylprednisolone , 168
IV prednisone , 168
third laparotomy , 216
three new necrotic lesions , 216
necrotic lesion on the left lobe of the liver , 216
fourth laparotomy , 264
segmental enterectomy with anastomosis , 264
cholecystectomy , 264
anastomotic leak , 264
gangrenous gallbladder , 264
died , 360
septic shock , 360
multiple organ failure , 360
weight loss , -1 year
myalgias , -1 year
fever , -1 year
skin erythema , -1 year
deterioration of renal function , -1 year
new onset of diabetes mellitus Type II , -1 year
hypertension , -1 year
diagnosis of PAN , -6 months
diagnosis of HBV infection , -6 months
presence of HBsAg , 0
presence of HBeAg , 0
presence of Anti-HBcAb , 0
absence of Anti-HBsAb , 0
absence of Anti-HBeAb , 0
